Deborah Rudin

552 total citations
36 papers, 355 citations indexed

About

Deborah Rudin is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, Deborah Rudin has authored 36 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Clinical Psychology, 14 papers in Cellular and Molecular Neuroscience and 9 papers in Genetics. Recurrent topics in Deborah Rudin's work include Psychedelics and Drug Studies (15 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Blood disorders and treatments (9 papers). Deborah Rudin is often cited by papers focused on Psychedelics and Drug Studies (15 papers), Neurotransmitter Receptor Influence on Behavior (14 papers) and Blood disorders and treatments (9 papers). Deborah Rudin collaborates with scholars based in Switzerland, United States and Austria. Deborah Rudin's co-authors include Matthias E. Liechti, Dino Luethi, Urs Duthaler, Stephan Krähenbühl, Penny Post, Balasubramanian Arunachalam, Harald H. Sitte, Manuel Haschke, Isabelle Straumann and Nimmy Varghese and has published in prestigious journals such as Neuropsychopharmacology, Biochemical Pharmacology and Molecular Psychiatry.

In The Last Decade

Deborah Rudin

32 papers receiving 355 citations

Peers

Deborah Rudin

CMN

TOXIC

Thomas W. Flanagan United States

Stephen J. Chapman United States

Flavio Zancanaro Italy

Eline Pottie Belgium

Hiroyuki Inoue Japan

Merja A. Neukamm Germany

Douwe de Boer Netherlands

D. Noel Sims Australia

Jean‐François Wiart France

P. Anantha Reddy United States

Thomas W. Flanagan United States

Deborah Rudin

282 ×1.7

160 ×1.3

CMN

128 ×1.5

128 ×2.0

11 ×0.2

TOXIC

Citations per year, relative to Deborah Rudin Deborah Rudin (= 1×) peers Thomas W. Flanagan

Countries citing papers authored by Deborah Rudin

Since Specialization

Citations

This map shows the geographic impact of Deborah Rudin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Rudin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Rudin more than expected).

Fields of papers citing papers by Deborah Rudin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Rudin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Rudin. The network helps show where Deborah Rudin may publish in the future.

Co-authorship network of co-authors of Deborah Rudin

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Rudin. A scholar is included among the top collaborators of Deborah Rudin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Rudin. Deborah Rudin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomann, Jan, Deborah Rudin, Sarah Kraus, et al.. (2025). Liquid chromatography–tandem mass spectrometry–based pharmacokinetic and metabolic analysis of 4-bromo-2,5-dimethoxyphenethylamine and its metabolites in human plasma. Drug Metabolism and Disposition. 53(6). 100086–100086. 2 indexed citations

Straumann, Isabelle, Patrick Vizeli, Anne Eckert, et al.. (2025). Acute effects of MDMA, MDA, lysine-MDMA, and lysine-MDA in a randomized, double-blind, placebo-controlled, crossover trial in healthy participants. Neuropsychopharmacology. 51(2). 476–485.

Holze, Friederike, M. Madsen, Claus Svarer, et al.. (2024). Ketanserin exhibits dose- and concentration-proportional serotonin 2A receptor occupancy in healthy individuals: Relevance for psychedelic research. European Neuropsychopharmacology. 88. 43–48. 11 indexed citations

Rodieux, Frédérique, Victoria C. Ziesenitz, Andrew Atkinson, et al.. (2024). Pharmacokinetics‐Based Pediatric Dose Evaluation and Optimization Using Saliva – A Case Study. The Journal of Clinical Pharmacology. 64(7). 810–819. 1 indexed citations

Arias, Hugo R., Deborah Rudin, Dustin J. Hines, et al.. (2024). The novel non-hallucinogenic compound DM506 (3-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indole) induces sedative- and anxiolytic-like activity in mice by a mechanism involving 5-HT2A receptor activation. European Journal of Pharmacology. 966. 176329–176329. 6 indexed citations

Müller, Lorenz, A. Becker, Aaron Klaiber, et al.. (2024). Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology. 50(6). 1008–1016. 3 indexed citations

Luethi, Dino, Deborah Rudin, Isabelle Straumann, et al.. (2024). Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers. Journal of Chromatography B. 1238. 124123–124123. 5 indexed citations

Ley, Laura, Isabelle Straumann, A. Becker, et al.. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Neuroscience Applied. 2. 103377–103377.

Rudin, Deborah, et al.. (2023). Classic psychedelics do not affect T cell and monocyte immune responses. Frontiers in Psychiatry. 14. 1042440–1042440. 6 indexed citations

10.

Ley, Laura, Isabelle Straumann, A. Becker, et al.. (2023). Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Translational Psychiatry. 13(1). 172–172. 54 indexed citations

11.

Hsiao, Amber, John Hansen, Ned Lewis, et al.. (2022). Safety of recombinant quadrivalent influenza vaccine compared to inactivated influenza vaccine in Chinese adults: An observational study. Vaccine. 40(5). 774–779. 2 indexed citations

12.

Rudin, Deborah, Dino Luethi, Therese Ku, et al.. (2021). Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram. RSC Medicinal Chemistry. 12(7). 1174–1186. 11 indexed citations

13.

Rudin, Deborah, Matthias E. Liechti, & Dino Luethi. (2021). Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology. 343. 113778–113778. 37 indexed citations

14.

Maier, Julian, Deborah Rudin, Marco Niello, et al.. (2021). α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter. Neuropharmacology. 190. 108570–108570. 14 indexed citations

15.

Maier, Julian, Marco Niello, Deborah Rudin, Lynette C. Daws, & Harald H. Sitte. (2021). The Interaction of Organic Cation Transporters 1-3 and PMAT with Psychoactive Substances. Handbook of experimental pharmacology. 266. 199–214. 17 indexed citations

16.

Rudin, Deborah, Luisa Ibáñez, Evangelia Liakoni, et al.. (2020). Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations. Genes. 11(11). 1275–1275. 8 indexed citations

17.

Rudin, Deborah, Luisa Ibáñez, Evangelia Liakoni, et al.. (2020). High-Throughput Sequencing to Investigate Associations Between HLA Genes and Metamizole-Induced Agranulocytosis. Frontiers in Genetics. 11. 951–951. 3 indexed citations

18.

Rudin, Deborah, Catherine E. Housecroft, Edwin C. Constable, et al.. (2019). Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Biochemical Pharmacology. 163. 345–356. 15 indexed citations

19.

Luethi, Dino, Melanie Walter, Xun Zhou, et al.. (2019). Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones. Frontiers in Pharmacology. 10. 438–438. 26 indexed citations

20.

Duthaler, Urs, et al.. (2018). N-demethylation of N-methyl-4-aminoantipyrine, the main metabolite of metamizole. European Journal of Pharmaceutical Sciences. 120. 172–180. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact